Applying the 2005 Canadian Hypertension Education Program recommendations: 2. Assessing and reducing global atherosclerotic risk among hypertensive patients

Hemmelgarn, Brenda R.; Grover, Steven; Feldman, Ross D.
September 2005
CMAJ: Canadian Medical Association Journal;9/13/2005, Vol. 173 Issue 6, p593
Academic Journal
Discusses the strategies for assessing and reducing atherosclerotic risk among hypertensive patients. Connection between hypertension and cardiovascular disease; Effect of antihypertensive treatment on the risk of coronary artery disease and cerebrovascular events; Methods to calculate the absolute cardiovascular risk of a patient; Analysis of cases involving patients with hypertension.


Related Articles

  • GP Business: Hypertension - part two. Newson, Louise // GP: General Practitioner;6/21/2004, p49 

    The latest British Hypertension Society guidelines are similar in many respects to the previous guidelines. They align with European Society guidelines for the classification of hypertension. Mild disease is defined as a blood pressure of 140-159/90-99 mmHg, moderate hypertension as...

  • New Insight of Morning Blood Pressure Surge Into the Triggers of Cardiovascular Disease--Synergistic Resonance of Blood Pressure Variability. Kazuomi Kario // American Journal of Hypertension;Jan2016, Vol. 29 Issue 1, p14 

    The author discusses the study on the association of morning blood pressure (BP) surge with coronary events in medicated elderly hypertensive patients. He mentions the importance of the near identical hazard ratios of the patients between stroke and coronary events, failure of the study to...

  • `Borderline' blood pressure risky.  // Executive Health's Good Health Report;May97, Vol. 33 Issue 8, p2 

    Reports on a new study which reveals that borderline (only slightly above normal) blood pressure increases the risk for heart and blood disease, including stroke. Comments from Christopher J. O'Donnel of Framingham Heart Study; Systolic and diastolic readings; Need for blood pressure-lowering...

  • Blood pressure reduction in elderly patients with hypertension decreases risk of adverse cardiovascular outcomes. Bangalore, Sripal; Doran, Bethany // Evidence Based Medicine;Oct2014, Vol. 19 Issue 5, p169 

    The authors reflect on the study "Effects of antihypertensive treatment in patients over 65 years of age: a meta-analysis of randomised controlled studies" by A. Briasoulis and others, in the periodical "Heart" in 2014. Topics discussed include examining the effect of antihypertensive treatment...

  • Commentary: Changing population blood pressure levels. Neal, Bruce // BMJ: British Medical Journal (International Edition);04/14/2001, Vol. 322 Issue 7291, p888 

    Offers the author's thoughts on the changing population blood pressure levels. Risk factors associated with high blood pressure and premature cardiovascular disease; Reasons why efforts to prevent diseases related to blood pressure have concentrated primarily on drug-based interventions among...

  • Adherence: the holy grail of hypertension.  // Australian Journal of Pharmacy;Feb2012, Vol. 93 Issue 1101, p30 

    The article discusses the need to improve adherence rates in patients with hypertension, considered as the deadliest and most common cardiovascular risk factor. It explores the consequences of non-adherence to hypertension medication, and describes tools that can be used by pharmacists in...

  • Effect of the angiotensin II receptor antagonist olmesartan on morning home blood pressure in hypertension: HONEST Study at 16 weeks. Kario, K; Saito, I; Kushiro, T; Teramukai, S; Ishikawa, Y; Hiramatsu, K; Kobayashi, F; Shimada, K // Journal of Human Hypertension;Dec2013, Vol. 27 Issue 12, p721 

    Morning home blood pressure (BP) levels are more closely associated with cardiovascular risk than clinic BP levels. However, control of morning home BP has been worse than that of clinic BP in clinical practice. We examined the effects of olmesartan-based treatment using data (n=21 341) from the...

  • Is SBP reduction in mild hypertension cost effective?  // PharmacoEconomics & Outcomes News;Mar2014, Vol. 698 Issue 1, p6 

    The article discusses the results of a study which showed the cost effectiveness of lowering systolic blood pressure (SBP) in mild hypertensive patients who are at risk of cardiovascular disease (CVD), referencing a research in the February 14, 2014 issue of the journal "Clinical Therapeutics."

  • New Cardiovascular Risk Factors and Their Use for an Accurate Cardiovascular Risk Assessment in Hypertensive Patients. TAUTU, Oana-Florentina; DARABONT, Roxana; ONCIUL, Sebastian; DEACONU, Alexandru; COMANESCU, Ioana; ANDREI, Radu Dan; DRAGOESCU, Bogdan; CINTEZA, Mircea; DOROBANTU, Maria // Maedica - a Journal of Clinical Medicine;2014, Vol. 9 Issue 2, p127 

    Objectives: To analyze the predictive value of new cardiovascular (CV) risk factors for CV risk assessment in the adult Romanian hypertensive (HT) population. Methods: Hypertensive adults aged between 40-65 years of age, identified in national representative SEPHAR II survey were evaluated by...

  • Disparities in Access to Care Among US Adults With Self-Reported Hypertension. Fang, Jing; Yang, Quanhe; Ayala, Carma; Loustalot, Fleetwood // American Journal of Hypertension;Nov2014, Vol. 27 Issue 11, p1377 

    BACKGROUND Hypertension is a major risk factor for cardiovascular disease. Access to care has been identified as a significant factor affecting hypertension treatment and control. We examined disparities in access to care among US adults with self-reported hypertension. METHODS Using Behavioral...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics